Adoption of a Novel Vasopressor Agent in Critically Ill Adults.
作者信息
Vail Emily A, Bosch Nicholas A, Law Anica C, Gershengorn Hayley B, Wunsch Hannah, Walkey Allan J
机构信息
University of Pennsylvania Philadelphia, Pennsylvania.
Penn Center for Perioperative Outcomes Research and Transformation Philadelphia, Pennsylvania.
出版信息
Ann Am Thorac Soc. 2023 Nov;20(11):1662-1667. doi: 10.1513/AnnalsATS.202306-540RL.
Abstract
摘要
相似文献
1
Adoption of a Novel Vasopressor Agent in Critically Ill Adults.在危重症成年患者中采用一种新型血管加压药
Ann Am Thorac Soc. 2023 Nov;20(11):1662-1667. doi: 10.1513/AnnalsATS.202306-540RL.
2
CCCS-SSAI WikiRecs Clinical Practice Guideline: vasopressor blood pressure targets in critically ill adults with hypotension.CCCS-SSAI维基推荐临床实践指南：成人危重症低血压患者血管升压药的血压目标
Can J Anaesth. 2017 Jul;64(7):763-765. doi: 10.1007/s12630-017-0878-0. Epub 2017 May 11.
3
Droxidopa for Vasopressor Weaning in Critically Ill Patients with Persistent Hypotension: A Multicenter, Retrospective, Single-Arm Observational Study.去氧肾上腺素用于持续性低血压危重症患者撤停血管升压药：一项多中心、回顾性、单臂观察性研究
J Intensive Care Med. 2025 Mar;40(3):239-246. doi: 10.1177/08850666241270089. Epub 2024 Aug 7.
4
CCCS-SSAI WikiRecs clinical practice guideline: vasopressor blood pressure targets in critically ill adults with hypotension and vasopressor use in early traumatic shock.CCCS-SSAI维基推荐临床实践指南：成人危重症低血压患者的血管升压药血压目标及早期创伤性休克中的血管升压药使用
Intensive Care Med. 2017 Jul;43(7):1062-1064. doi: 10.1007/s00134-016-4539-5. Epub 2017 May 11.
5
A PILOT STUDY OF ANGIOTENSIN II AS PRIMARY VASOPRESSOR IN CRITICALLY ILL ADULTS WITH VASODILATORY HYPOTENSION: THE ARAMIS STUDY.血管紧张素II作为血管扩张性低血压成年危重症患者主要血管加压药的初步研究：ARAMIS研究
Shock. 2023 May 1;59(5):691-696. doi: 10.1097/SHK.0000000000002109. Epub 2023 Mar 18.
6
Automated Blood Pressure Control.自动血压控制
Semin Respir Crit Care Med. 2021 Feb;42(1):47-58. doi: 10.1055/s-0040-1713083. Epub 2020 Aug 3.
7
VASOPRESSOR-RESISTANT HYPOTENSION, COMBINATION VASOPRESSOR THERAPY, AND SHOCK PHENOTYPES IN CRITICALLY ILL ADULTS WITH VASODILATORY SHOCK.血管扩张性休克危重症成人中血管加压剂抵抗性低血压、联合血管加压剂治疗和休克表型。
Shock. 2022 Oct 1;58(4):260-268. doi: 10.1097/SHK.0000000000001980. Epub 2022 Aug 18.
8
Early Vasopressor Initiation Increases Mortality in Patients With Septic Shock: Less Intensive Intervention or More Critically Ill Patients?早期使用血管升压药会增加感染性休克患者的死亡率：是干预强度较低还是患者病情更危重？
Crit Care Med. 2022 Apr 1;50(4):e402-e403. doi: 10.1097/CCM.0000000000005418.
9
Ten tips to optimize vasopressors use in the critically ill patient with hypotension.优化低血压危重症患者血管升压药使用的十条建议。
Intensive Care Med. 2022 Jun;48(6):736-739. doi: 10.1007/s00134-022-06708-y. Epub 2022 May 3.
10
A systematic review of vasopressor blood pressure targets in critically ill adults with hypotension.对成人重症低血压患者血管升压药血压目标的系统评价。
Can J Anaesth. 2017 Jul;64(7):703-715. doi: 10.1007/s12630-017-0877-1. Epub 2017 May 11.
引用本文的文献
1
Vasoactive Agents in Burn Patients: Perspectives on Angiotensin-II.烧伤患者的血管活性药物：关于血管紧张素-II的观点
J Burn Care Res. 2025 Aug 12;46(3):515-525. doi: 10.1093/jbcr/irae208.
本文引用的文献
1
Uptake and Accuracy of the Diagnosis Code for COVID-19 Among US Hospitalizations.美国住院患者 COVID-19 诊断代码的使用率和准确性。
JAMA. 2020 Dec 22;324(24):2553-2554. doi: 10.1001/jama.2020.20323.
2
A Multicenter Observational Cohort Study of Angiotensin II in Shock.一项关于休克中血管紧张素 II 的多中心观察性队列研究。
J Intensive Care Med. 2022 Jan;37(1):75-82. doi: 10.1177/0885066620972943. Epub 2020 Nov 24.
3
Use of Vasoactive Medications after Cardiac Surgery in the United States.美国心脏手术后血管活性药物的使用情况。
Ann Am Thorac Soc. 2021 Jan;18(1):103-111. doi: 10.1513/AnnalsATS.202005-465OC.
4
Angiotensin II Infusion for Shock: A Multicenter Study of Postmarketing Use.血管紧张素 II 输注治疗休克：上市后使用的多中心研究。
Chest. 2021 Feb;159(2):596-605. doi: 10.1016/j.chest.2020.08.2074. Epub 2020 Aug 31.
5
Modern Treatment Trends and Outcomes of Pulmonary Embolism With and Without Hemodynamic Significance.有和无血流动力学意义的肺栓塞的现代治疗趋势和结局。
Ann Thorac Surg. 2020 Nov;110(5):1534-1540. doi: 10.1016/j.athoracsur.2020.02.041. Epub 2020 Mar 26.
6
Validation of ICD-10 codes shows intracranial venous thrombosis incidence to be higher than previously reported.ICD-10 编码的验证表明，颅内静脉血栓形成的发病率高于之前的报告。
Health Inf Manag. 2020 Jan;49(1):58-61. doi: 10.1177/1833358318819105. Epub 2018 Dec 18.
7
Importance of Early Insertion of Inferior Vena Cava Filters in Unstable Patients with Acute Pulmonary Embolism.急性肺栓塞不稳定患者下腔静脉滤器早期置入的重要性。
Am J Med. 2018 Sep;131(9):1104-1109. doi: 10.1016/j.amjmed.2018.05.023. Epub 2018 Jun 12.
8
Echocardiogram in the Evaluation of Hemodynamically Stable Acute Pulmonary Embolism: National Practices and Clinical Outcomes.超声心动图在血流动力学稳定的急性肺栓塞评估中的应用：国家实践与临床结局。
Ann Am Thorac Soc. 2018 May;15(5):581-588. doi: 10.1513/AnnalsATS.201707-577OC.
9
Angiotensin II for the Treatment of Vasodilatory Shock.血管紧张素 II 用于治疗血管舒张性休克。
N Engl J Med. 2017 Dec 28;377(26):2604. doi: 10.1056/NEJMc1714511.
10
Adaptation and Validation of the Combined Comorbidity Score for ICD-10-CM.ICD-10-CM合并症综合评分的适应性与验证
Med Care. 2017 Dec;55(12):1046-1051. doi: 10.1097/MLR.0000000000000824.
Zotero 插件